UK biotech Archives -

In only its second year of operations, Cambridge, UK startup Dunad Therapeutics has already attracted a big pharma

UK biotech Dunad inks $1.3bn Novartis deal for its protein degraders

https://pharmaphorum.com/news/uk-biotech-dunad-inks-1-3bn-novartis-deal-for-its-protein-degraders/

News/ News/ Sales and Marketing

Oxford Nanopore makes stellar debut on UK stock market

Phil Taylor financing, Gene Sequencing, genomics, IPO, Oxford Nanopore, UK biotech 0 Comment

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock

Oxford Nanopore makes stellar debut on UK stock market

https://pharmaphorum.com/news/oxford-nanopore-makes-stellar-debut-on-uk-stock-market/

Building a better future for people with rare diseases in all four UK nations

News/ News/ R&D

Dementia, cancer headline UK’s 10-year plan for life sciences sector

Phil Taylor ABPI, BIA, Life Sciences, UK, UK biotech 0 Comment

The UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries

Dementia, cancer headline UK’s 10-year plan for life sciences sector

https://pharmaphorum.com/news/dementia-cancer-headline-uks-10-year-plan-for-life-sciences-sector/

R&D/ Views & Analysis/ Views and analysis

Clive Dix: Rebuilding UK biotech

Richard Staines C4X Discovery, UK biotech, UK Leaders 0 Comment

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last

Clive Dix: Rebuilding UK biotech

https://pharmaphorum.com/views-and-analysis/clive-dix-rebuilding-uk-biotech/

The rise and rise of digital health investment

News/ News/ R&D

UK biotech investment at record levels amid COVID-19

Phil Taylor financing, investment, IPO, UK, UK biotech, venture capital 0 Comment

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last

UK biotech investment at record levels amid COVID-19

https://pharmaphorum.com/news/uk-biotech-investment-at-record-levels-amid-covid-19/

News/ News/ Oncology

UK cancer mutation testing firm Biofidelity raises $12m

Phil Taylor Biofidelity, diagnostics, financing, Molecular diagnostics, Oncology, UK biotech 0 Comment

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect

UK cancer mutation testing firm Biofidelity raises $12m

https://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/

News/ News/ R&D

GW Pharma and Orchard biggest UK biotech fundraisers in Q1

Andrew McConaghie UK biotech 0 Comment

The UK biotech sector has enjoyed a ‘solid start’ in early 2018, with GW Pharma and Orchard Therapeutics dominating the funding

GW Pharma and Orchard biggest UK biotech fundraisers in Q1

https://pharmaphorum.com/news/gw-pharma-orchard-biggest-uk-biotech-fundraisers-q1/

Healthcare/ News/ UK & Europe

Gene sequencing upstart Oxford Nanopore raises another $140m

Andrew McConaghie Oxford Nanopore, UK biotech 0 Comment

Gene sequencing upstart Oxford Nanopore raises another $140m in its bid to enable the analysis of “any living thing, by anyone, anywhere.”

Gene sequencing upstart Oxford Nanopore raises another $140m

https://pharmaphorum.com/news/gene-sequencing-upstart-oxford-nanopore-raises-another-140m/

News/ R&D/ UK & Europe

Prokarium raises $10m for ‘game changer’ synthetic bio vaccines

Andrew McConaghie Prokarium, UK biotech, vaccines 0 Comment

UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation

Prokarium raises $10m for ‘game changer’ synthetic bio vaccines

https://pharmaphorum.com/news/prokarium-raises-10m-game-changer-synthetic-bio-vaccines/

Trending

UK biotech

Login